HIPAA Pen Testing

HIPAA Pen Testing & VAPT

Security Rule compliance pen testing for covered entities and business associates

Continuous HIPAA pen testing and VAPT across the ePHI data flow — Security Rule technical safeguards (45 CFR 164.312), administrative safeguards technical implementation (164.308), risk analysis input, HITRUST CSF-aligned evidence, and OCR-ready reporting for covered entities, business associates, and healthcare SaaS.

How It Works

Four steps. One continuous pen testing loop.

1

ePHI Scope Discovery

Identify every system that creates, receives, maintains, or transmits electronic Protected Health Information (ePHI). HIPAA pen testing scope spans the full ePHI data flow — web apps, mobile apps, APIs, cloud storage, EHR integrations, and third-party processors covered by Business Associate Agreements.

2

Security Rule Pen Testing

AI-driven HIPAA pen testing executes against technical safeguards required by 45 CFR 164.312 — access control, audit controls, integrity, person-or-entity authentication, and transmission security — plus administrative safeguards that have technical implementation (164.308).

3

Risk Analysis Input

Findings integrate into the formal HIPAA risk analysis required by 164.308(a)(1)(ii)(A). Every vulnerability is scored for likelihood, severity, and business impact — producing exactly the risk evidence HIPAA covered entities and business associates must document.

4

OCR & BAA Ready

Reports are formatted for OCR (HHS Office for Civil Rights) inquiries, business associate audits, and HITRUST CSF validated assessments. Covered entities and business associates receive deliverables suitable for Business Associate Agreement compliance evidence and OCR audit responses.

Key Features

Complete HIPAA Security Rule and HITRUST CSF pen testing coverage

164.312(a) Access Control

HIPAA pen testing of unique user identification, emergency access procedures, automatic logoff, and encryption/decryption controls across ePHI-handling systems

164.312(b) Audit Controls

Validation of hardware, software, and procedural mechanisms that record and examine activity in ePHI systems — pen testing exercises the audit-logging pipeline against real adversary behaviour

164.312(c) Integrity Controls

Testing of mechanisms that authenticate ePHI and ensure it has not been improperly altered or destroyed — including tamper detection and database-level integrity controls

164.312(d) Person-or-Entity Authentication

HIPAA pen testing of authentication controls including MFA implementation, password policies, biometric authentication, and SSO integrations

164.312(e) Transmission Security

TLS implementation, VPN configuration, email encryption, and ePHI-in-transit protection across cloud and third-party communications channels

164.308(a)(1) Risk Analysis

Technical vulnerability data feeding the formal HIPAA risk analysis required by 45 CFR 164.308(a)(1)(ii)(A) — with likelihood, severity, and business impact scoring

164.308(a)(8) Technical Evaluation

Continuous HIPAA VAPT satisfying the 'periodic technical and non-technical evaluation' requirement with timestamped evidence across the evaluation period

ePHI Data Flow Pen Testing

Validation of ePHI handling across web applications, mobile apps, APIs, cloud storage, EHR integrations, and third-party processors covered by Business Associate Agreements

Business Associate Pen Testing

Comprehensive VAPT of business associate systems and services — reports suitable for BAA compliance evidence, covered entity vendor security questionnaires, and HIPAA audit responses

Medical Device Security Testing

Specialised scope for medical device manufacturers and healthcare SaaS integrating with devices — covering the connected-device attack surface alongside standard web and API pen testing

Breach Simulation Scenarios

Controlled simulation of common ePHI breach scenarios — credential theft, insider threat, ransomware, phishing-driven account takeover — producing the pre-incident evidence breach-prevention programmes require

HITRUST CSF Mapping

Automatic mapping of HIPAA pen testing findings to HITRUST CSF domains and controls — accelerating HITRUST r2 validated assessment scoring and reducing duplicate testing

Benefits

Why teams choose TigerStrike for their security needs

Covered Entity & Business Associate Coverage

HIPAA pen testing scoped for both covered entities (health plans, healthcare clearinghouses, providers) and business associates (SaaS vendors, cloud services, IT contractors). Business associate pen testing produces the evidence covered entity customers require before signing or renewing a BAA.

Covered Entity & Business Associate Coverage

Security Rule Technical Safeguards

Complete AI-driven pen testing coverage of 45 CFR 164.312 technical safeguards — access control (unique user identification, emergency access, automatic logoff, encryption/decryption), audit controls, integrity, authentication, and transmission security.

Security Rule Technical Safeguards

164.308(a)(8) Technical Evaluation

HIPAA 164.308(a)(8) requires 'periodic technical and non-technical evaluation' demonstrating that security policies and procedures meet Security Rule requirements. Continuous HIPAA VAPT produces exactly this technical evaluation evidence rather than a stale annual report.

164.308(a)(8) Technical Evaluation

HITRUST CSF-Aligned Pen Testing

Every HIPAA pen testing finding automatically maps to HITRUST CSF technical control requirements across all 19 domains. Organisations pursuing HITRUST r2 validated assessments use TigerStrike evidence to accelerate certification and improve control effectiveness scoring.

HITRUST CSF-Aligned Pen Testing

ePHI-Safe Pen Testing

HIPAA pen testing operates with ePHI-safe controls — read-only assessment modes, synthetic test data injection, redaction of any observed ePHI in reports, and BAA-covered handling of all assessment artefacts. Testing can be scoped to staging environments with production-equivalent data models.

ePHI-Safe Pen Testing

Breach Prevention Evidence

Proactive identification and validated exploitation of vulnerabilities that could trigger reportable breaches under the HIPAA Breach Notification Rule. OCR has increasingly cited the absence of regular HIPAA pen testing as an aggravating factor in post-breach enforcement — continuous VAPT is the defensible evidence trail.

Breach Prevention Evidence

Frequently Asked Questions

Ready to get started?

Start securing your applications today with TigerStrike's AI-powered penetration testing platform.

Book a Demo